ArticlePharmacogenomics and personalized medicine2013

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.

Xuemei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.